Fig. 3: miR-27b suppresses the tumorigenesis and promotes therapeutic effect with PTX of breast cancer in vivo. | Cell Death & Disease

Fig. 3: miR-27b suppresses the tumorigenesis and promotes therapeutic effect with PTX of breast cancer in vivo.

From: miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells

Fig. 3: miR-27b suppresses the tumorigenesis and promotes therapeutic effect with PTX of breast cancer in vivo.

a, b The xenograft were built by BCap37 cells transfected with miR-27b inhibitors with subsequent treatment of miR-27b inhibitors. The tumor volumes were measured and quantified. d, e The xenograft were built by Bads-200 cells stable expressing miR-27b with following treatment of PTX. c, f Representative images of tumor samples that were stained with hematoxylin and eosin (H&E) and Ki67 by IHC. Scale bars: (main) 100 μm; (insets) 25 μm

Back to article page